{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:23:00Z","timestamp":1783200180347,"version":"3.54.6"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CN00000041"],"award-info":[{"award-number":["CN00000041"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CUP B93D21010860004"],"award-info":[{"award-number":["CUP B93D21010860004"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.nbd.2025.107192","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:34:23Z","timestamp":1763631263000},"page":"107192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["From molecular convergence to clinical divergence: Comparative pathogenic mechanisms and therapeutic trajectories in C9orf72-ALS\/FTD and myotonic dystrophy"],"prefix":"10.1016","volume":"217","author":[{"given":"Claudia","family":"Alberti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Parente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Ada","family":"Sansone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.107192_bb0005","doi-asserted-by":"crossref","first-page":"1181040","DOI":"10.3389\/fcell.2023.1181040","article-title":"Promising AAV.U7snRNAs vectors targeting DMPK improve DM1 hallmarks in patient-derived cell lines","volume":"11","author":"Almeida","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.nbd.2025.107192_bb0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mus.28308","article-title":"Mortality trends and causes of death in myotonic dystrophy Type 1 patients from the UK clinical practice research datalink","volume":"71","author":"Alsaggaf","year":"2025","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2025.107192_bb0015","author":"AMO Pharma"},{"key":"10.1016\/j.nbd.2025.107192_bb0020","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1038\/s41467-018-06206-0","article-title":"Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies","volume":"9","author":"Antoury","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.107192_bb0035","author":"Avidity Biosciences"},{"key":"10.1016\/j.nbd.2025.107192_bb0040","author":"Avidity Biosciences"},{"key":"10.1016\/j.nbd.2025.107192_bb0045","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1093\/brain\/awae109","article-title":"Apilimod dimesylate in C9orf72 amyotrophic lateral sclerosis: a randomized phase 2a clinical trial","volume":"147","author":"Babu","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107192_bb0050","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","article-title":"C9orf72-mediated ALS and FTD: multiple pathways to disease","volume":"14","author":"Balendra","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0055","article-title":"Biomolecular condensates can enhance pathological RNA clustering","author":"Banerjee","year":"2024","journal-title":"Res. Sq. [preprint]"},{"key":"10.1016\/j.nbd.2025.107192_bb0060","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ajhg.2017.01.033","article-title":"CpG methylation, a parent-of-origin effect for maternal-biased transmission of congenital myotonic dystrophy","volume":"100","author":"Barb\u00e9","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2025.107192_bb0065","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1080\/15548627.2021.1872189","article-title":"C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels","volume":"17","author":"Beckers","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.nbd.2025.107192_bb0070","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1540-8167.2011.02200.x","article-title":"Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population","volume":"22","author":"Bhakta","year":"2011","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.nbd.2025.107192_bb0075","series-title":"GeneReviews\u00ae","article-title":"Myotonic dystrophy Type 1 [Updated 2024 Nov 14]","author":"Bird","year":"1999"},{"key":"10.1016\/j.nbd.2025.107192_bb0080","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1093\/hmg\/ddv219","article-title":"Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy","volume":"24","author":"Bisset","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.107192_bb0085","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.molcel.2017.02.013","article-title":"Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics","volume":"65","author":"Boeynaems","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2025.107192_bb0090","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100574","article-title":"Reduced autophagy upon C9orf72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders","volume":"39","author":"Boivin","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2025.107192_bb0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ejhg.2016.148","article-title":"Identification and characterization of 5' CCG interruptions in complex DMPK expanded alleles","volume":"25","author":"Botta","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2025.107192_bb0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-022-04436-3","article-title":"TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A","volume":"603","author":"Brown","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.107192_bb0105","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(16)00737-6","article-title":"The frontotemporal dementia-motor neuron disease continuum","volume":"388","author":"Burrell","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2025.107192_bb0110","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/ana.27068","article-title":"RAN translation of C9orf72-related dipeptide repeat proteins in zebrafish recapitulates hallmarks of amyotrophic lateral sclerosis and identifies hypothermia as a therapeutic strategy","volume":"96","author":"Burrows","year":"2024","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41434-023-00418-w","article-title":"Artificial microRNA suppresses C9orf72 variants and decreases toxic dipeptide repeat proteins in vivo","volume":"31","author":"Cabrera","year":"2024","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2025.107192_bb0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fnmol.2013.00057","article-title":"Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy","volume":"6","author":"Caillet-Boudin","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2025.107192_bb0125","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1093\/brain\/awae168","article-title":"Failure of C9orf72 sense repeat-targeting antisense oligonucleotides: lessons learned and the path forward","volume":"147","author":"Cammack","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107192_bb0130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4081\/918","article-title":"Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy","volume":"48","author":"Cardani","year":"2004","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.nbd.2025.107192_bb0135","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1093\/hmg\/ddw266","article-title":"Dmpk gene deletion or antisense knockdown does not compromise cardiac or skeletal muscle function in mice","volume":"25","author":"Carrell","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.107192_bb0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1097-2765(02)00572-5","article-title":"Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing","volume":"10","author":"Charlet-B","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2025.107192_bb0145","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1038\/ncomms3044","article-title":"Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules","volume":"4","author":"Childs-Disney","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.107192_bb0150","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.molcel.2005.09.002","article-title":"Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF","volume":"20","author":"Cho","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2025.107192_bb0160","article-title":"FDA grants breakthrough therapy designation for AOC 1001 in myotonic dystrophy type 1","author":"Ciccone","year":"2024","journal-title":"Neurol. Live."},{"key":"10.1016\/j.nbd.2025.107192_bb0165","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1212\/CON.0000000000001506","article-title":"Frontotemporal dementia","volume":"30","author":"Clark","year":"2024","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.nbd.2025.107192_bb0170","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.mcp.2016.06.001","article-title":"Improved PCR based methods for detecting C9orf72 hexanucleotide repeat expansions","volume":"30","author":"Cleary","year":"2016","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.nbd.2025.107192_bb0180","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69269","article-title":"Translational control of polyamine metabolism by CNBP is required for Drosophila locomotor function","volume":"10","author":"Coni","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.nbd.2025.107192_bb0185","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/s41431-018-0156-9","article-title":"De novo repeat interruptions are associated with reduced somatic instability and mild or absent clinical features in myotonic dystrophy type 1","volume":"26","author":"Cumming","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2025.107192_bb0190","first-page":"1221","article-title":"Life expectancy and causes of death in patients with Myotonic Dystrophy Type 2","volume":"11","author":"Damen","year":"2024","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.nbd.2025.107192_bb0195","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1212\/01.WNL.0000054481.84978.F9","article-title":"Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum","volume":"60","author":"Day","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.107192_bb0200","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jamaneurol.2020.1087","article-title":"Use of multimodal imaging and clinical biomarkers in presymptomatic carriers of C9orf72 repeat expansion","volume":"77","author":"De Vocht","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9orf72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.107192_bb0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00401-017-1725-7","article-title":"In-depth clinico-pathological examination of RNA foci in a large cohort of C9orf72 expansion carriers","volume":"134","author":"DeJesus-Hernandez","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.107192_bb0215","series-title":"Myotonic Dystrophy Market Report. Myotonic Dystrophy Treatment Market Size, Drugs, Companies","author":"DelveInsight","year":"2025"},{"key":"10.1016\/j.nbd.2025.107192_bb0220","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ajhg.2021.03.011","article-title":"30 years of repeat expansion disorders: What have we learned and what are the remaining challenges?","volume":"108","author":"Depienne","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2025.107192_bb0225","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.expneurol.2007.11.020","article-title":"Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats","volume":"210","author":"Dhaenens","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0235","author":"Dyne Therapeutics"},{"key":"10.1016\/j.nbd.2025.107192_bb0240","author":"Dyne Therapeutics"},{"key":"10.1016\/j.nbd.2025.107192_bb0245","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13024-018-0274-4","article-title":"Long-read sequencing across the C9orf72 'GGGGCC' repeat expansion: implications for clinical use and genetic discovery efforts in human disease","volume":"13","author":"Ebbert","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2025.107192_bb0250","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13059-024-03171-4","article-title":"RExPRT: a machine learning tool to predict pathogenicity of tandem repeat loci","volume":"25","author":"Fazal","year":"2024","journal-title":"Genome Biol."},{"key":"10.1016\/j.nbd.2025.107192_bb0255","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1007\/s00415-024-12544-5","article-title":"Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study","volume":"271","author":"Fionda","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0260","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/brain\/awae336","article-title":"MBNL deficiency in motor neurons disrupts neuromuscular junction maintenance and gait coordination","volume":"148","author":"Frison-Roche","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107192_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114768","article-title":"DDX3X overexpression decreases dipeptide repeat proteins in a mouse model of C9ORF72-ALS\/FTD","volume":"376","author":"Fu","year":"2024","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0270","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.nmd.2016.10.003","article-title":"Cognitive decline over time in adults with myotonic dystrophy type 1: A 9-year longitudinal study","volume":"27","author":"Gallais","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.nbd.2025.107192_bb0275","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/mp.2015.159","article-title":"The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter","volume":"21","author":"Gijselinck","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2025.107192_bb0280","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026757","article-title":"The genetics of C9orf72 expansions","volume":"8","author":"Gijselinck","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.nbd.2025.107192_bb0285","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.celrep.2015.07.029","article-title":"MBNL sequestration by toxic RNAs and RNA mis-processing in the myotonic dystrophy brain","volume":"12","author":"Goodwin","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2025.107192_bb0290","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1056\/NEJMoa062800","article-title":"Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1","volume":"358","author":"Groh","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2025.107192_bb0295","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature13124","article-title":"C9orf72 nucleotide repeat structures initiate molecular cascades of disease","volume":"507","author":"Haeusler","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.107192_bb0300","first-page":"1715","article-title":"Myotonic dystrophy","volume":"28","author":"Hamel","year":"2022","journal-title":"Continuum (Minneap. Minn.)"},{"key":"10.1016\/j.nbd.2025.107192_bb0305","series-title":"Myotonic Dystrophy","author":"Harper","year":"2001"},{"key":"10.1016\/j.nbd.2025.107192_bb0310","first-page":"10","article-title":"Anticipation in myotonic dystrophy: new light on an old problem","volume":"51","author":"Harper","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2025.107192_bb0315","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1365-2443.2007.01112.x","article-title":"Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles","volume":"12","author":"Holt","year":"2007","journal-title":"Genes Cells"},{"key":"10.1016\/j.nbd.2025.107192_bb0320","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186416","article-title":"MBNL overexpression rescues cardiac phenotypes in a myotonic dystrophy type 1 heart mouse model","volume":"135","author":"Hu","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2025.107192_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108538","article-title":"Nuclear import receptors directly bind to arginine-rich dipeptide repeat proteins and suppress their pathological interactions","volume":"33","author":"Hutten","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2025.107192_bb0330","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s40478-019-0724-4","article-title":"C9orf72 intermediate expansions of 24-30 repeats are associated with ALS","volume":"7","author":"Iacoangeli","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2025.107192_bb0335","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/s41591-024-03190-5","article-title":"Increased frequency of repeat expansion mutations across different populations","volume":"30","author":"Iba\u00f1ez","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2025.107192_bb0340","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-007-0267-9","article-title":"Endoplasmic reticulum stress in myotonic dystrophy type 1 muscle","volume":"114","author":"Ikezoe","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.107192_bb0345","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41591-023-02788-5","article-title":"A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD","volume":"30","author":"Irwin","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2025.107192_bb0350","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.3390\/ijms23094622","article-title":"Molecular therapies for myotonic dystrophy Type 1: from small drugs to gene editing","volume":"23","author":"Izzo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.107192_bb0355","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bpj.2020.07.005","article-title":"Phase separation of toxic dipeptide repeat proteins related to C9orf72 ALS\/FTD","volume":"119","author":"Jafarinia","year":"2020","journal-title":"Biophys. J."},{"key":"10.1016\/j.nbd.2025.107192_bb0360","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature22386","article-title":"RNA phase transitions in repeat expansion disorders","volume":"546","author":"Jain","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.107192_bb0365","series-title":"MDA Clinical & Scientific Conference","article-title":"Initial results of the phase 2 open-label extension study of AOC 1001 in adults with myotonic dystrophy type 1: MARINA-OLE","author":"Johnson","year":"2024"},{"key":"10.1016\/j.nbd.2025.107192_bb0370","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41467-024-55550-x","article-title":"Dual-targeting CRISPR-CasRx reduces C9orf72 ALS\/FTD sense and antisense repeat RNAs in vitro and in vivo","volume":"16","author":"Kempthorne","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.107192_bb0375","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.3390\/ijms26115350","article-title":"Multisystem symptoms in myotonic dystrophy Type 1: A management and therapeutic perspective","volume":"26","author":"Kuntawala","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.107192_bb0380","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1254917","article-title":"Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells","volume":"345","author":"Kwon","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.107192_bb0385","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2869.2004.00385.x","article-title":"Sleep complaints in patients with myotonic dystrophy","volume":"13","author":"Laberge","year":"2004","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.nbd.2025.107192_bb0390","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1038\/s41467-023-41033-y","article-title":"Divergent single cell transcriptome and epigenome alterations in ALS and FTD patients with C9orf72 mutation","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.107192_bb0395","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000524734","article-title":"Global prevalence of myotonic dystrophy: an updated systematic review and meta-analysis","volume":"56","author":"Liao","year":"2022","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.nbd.2025.107192_bb0400","series-title":"Safety and Efficacy of DYNE-101 in Adults with DM1: Phase 1\/2 ACHIEVE Trial Data. MDA Clinical & Scientific Conference, Dallas, Texas, USA","author":"Lilleker","year":"2025"},{"key":"10.1016\/j.nbd.2025.107192_bb0405","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1062125","article-title":"Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9","volume":"293","author":"Liquori","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.107192_bb0410","doi-asserted-by":"crossref","DOI":"10.1172\/JCI189439","article-title":"CRISPR\/Cas13d targeting suppresses repeat-associated non-AUG translation of C9orf72 hexanucleotide repeat RNA","volume":"134","author":"Liu","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2025.107192_bb0415","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3389\/fneur.2018.00349","article-title":"Small molecules which improve pathogenesis of myotonic dystrophy Type 1","volume":"9","author":"L\u00f3pez-Morat\u00f3","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0420","series-title":"Mexiletine Program Myotonic Dystrophy Type 1 (DM1)-01 Program Update","author":"Lupin Neurosciences","year":"2024"},{"key":"10.1016\/j.nbd.2025.107192_bb0425","doi-asserted-by":"crossref","first-page":"gkaf253","DOI":"10.1093\/nar\/gkaf253","article-title":"High-throughput screen of 100 000 small molecules in C9orf72 ALS neurons identifies spliceosome modulators that mobilize G4C2 repeat RNA into nuclear export and repeat associated non-canonical translation","volume":"53","author":"Luteijn","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2025.107192_bb0430","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","article-title":"TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.107192_bb0435","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","article-title":"Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study","volume":"11","author":"Majounie","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0440","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.289.5485.1769","article-title":"Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat","volume":"289","author":"Mankodi","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.107192_bb0445","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1097-2765(02)00563-4","article-title":"Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy","volume":"10","author":"Mankodi","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2025.107192_bb0450","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.omtn.2019.01.010","article-title":"Artificial microRNAs targeting C9orf72 can reduce accumulation of intra-nuclear transcripts in ALS and FTD patients","volume":"14","author":"Martier","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.nbd.2025.107192_bb0455","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0460","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1212\/WNL.52.8.1658","article-title":"A 10-year study of mortality in a cohort of patients with myotonic dystrophy","volume":"52","author":"Mathieu","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.107192_bb0465","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41588-025-02172-8","article-title":"Base editing of trinucleotide repeats that cause Huntington's disease and Friedreich's ataxia reduces somatic repeat expansions in patient cells and in mice","volume":"57","author":"Matuszek","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2025.107192_bb0470","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41467-024-55548-5","article-title":"A high-fidelity CRISPR-Cas13 system improves abnormalities associated with C9orf72-linked ALS\/FTD","volume":"16","author":"McCallister","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.107192_bb0475","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41586-020-2625-x","article-title":"C9orf72 in myeloid cells suppresses STING-induced inflammation","volume":"585","author":"McCauley","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.107192_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.07.045","article-title":"Molecular impact of antisense oligonucleotide therapy in C9orf72-associated ALS","author":"McEachin","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2025.107192_bb0485","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/acn3.559","article-title":"Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers","volume":"5","author":"Meeter","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0490","article-title":"Patient dosing commenced for Phase 1\/2 ArthemiR trial of ATX-01 in myotonic dystrophy type 1","author":"Meglio","year":"2024","journal-title":"Neurol. Live"},{"key":"10.1016\/j.nbd.2025.107192_bb0495","doi-asserted-by":"crossref","DOI":"10.1177\/22143602251386258","article-title":"Predictors of respiratory failure and survival in myotonic dystrophy type 1","author":"Melone","year":"2025","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.nbd.2025.107192_bb0500","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbadis.2014.05.019","article-title":"Myotonic dystrophies: an update on clinical aspects, genetic, pathology, and molecular pathomechanisms","volume":"1852","author":"Meola","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2025.107192_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137620","article-title":"Sense and antisense DMPK RNA foci accumulate in DM1 tissues during development","volume":"10","author":"Michel","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.107192_bb0510","first-page":"ugae019","article-title":"C9orf72 repeat expansion creates the unstable folate-sensitive fragile site FRA9A. NAR","volume":"1","author":"Mirceta","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.nbd.2025.107192_bb0515","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1093\/hmg\/dds185","article-title":"Somatic instability of the expanded CTG triplet repeat in myotonic dystrophy type 1 is a heritable quantitative trait and modifier of disease severity","volume":"21","author":"Morales","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.107192_bb0520","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1093\/hmg\/ddaa123","article-title":"Longitudinal increases in somatic mosaicism of the expanded CTG repeat in myotonic dystrophy type 1 are associated with variation in age-at-onset","volume":"29","author":"Morales","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.107192_bb0525","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/hmg\/ddab243","article-title":"Myotonic dystrophy type 1 (DM1) clinical subtypes and CTCF site methylation status flanking the CTG expansion are mutant allele length-dependent","volume":"31","author":"Morales","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.107192_bb0530","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/hmg\/ddac231","article-title":"Individual-specific levels of CTG\u2022CAG somatic instability are shared across multiple tissues in myotonic dystrophy type 1","volume":"32","author":"Morales","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.107192_bb0535","article-title":"Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): protocol of an international natural history study","author":"Mul","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.nbd.2025.107192_bb0540","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1038\/s41598-017-02364-1","article-title":"Age-related penetrance of the C9orf72 repeat expansion","volume":"7","author":"Murphy","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.107192_bb0545","author":"Muscular Dystrophy Association"},{"key":"10.1016\/j.nbd.2025.107192_bb0550","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ana.23992","article-title":"Splicing biomarkers of disease severity in myotonic dystrophy","volume":"74","author":"Nakamori","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0555","article-title":"Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"67","author":"Nakamori","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.nbd.2025.107192_bb0560","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/s44319-024-00140-7","article-title":"Glucose hypometabolism prompts RAN translation and exacerbates C9orf72-related ALS\/FTD phenotypes","volume":"25","author":"Nelson","year":"2024","journal-title":"EMBO Rep."},{"key":"10.1016\/j.nbd.2025.107192_bb0565","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1007\/s00415-022-11165-0","article-title":"Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1)","volume":"269","author":"Nicoletti","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0570","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3389\/fneur.2019.01229","article-title":"Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1","volume":"10","author":"Nieuwenhuis","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0575","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1093\/hmg\/ddv064","article-title":"Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD","volume":"24","author":"Nordin","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.107192_bb0580","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cortex.2017.08.008","article-title":"The cognitive profile of myotonic dystrophy type 1: A systematic review and meta-analysis","volume":"95","author":"Okkersen","year":"2017","journal-title":"Cortex"},{"key":"10.1016\/j.nbd.2025.107192_bb0585","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.aaf1064","article-title":"C9orf72 is required for proper macrophage and microglial function in mice","volume":"351","author":"O'Rourke","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.107192_bb0590","author":"PepGen"},{"key":"10.1016\/j.nbd.2025.107192_bb0595","doi-asserted-by":"crossref","DOI":"10.4081\/ejh.2009.e18","article-title":"RNA\/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocytochemical study","volume":"53","author":"Perdoni","year":"2009","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.nbd.2025.107192_bb0600","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.nmd.2022.06.011","article-title":"Cognitive assessment in patients with myotonic dystrophy type 2","volume":"32","author":"Peric","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.nbd.2025.107192_bb0605","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2011.08.037","article-title":"Cardiac manifestations of myotonic dystrophy type 1","volume":"160","author":"Petri","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.nbd.2025.107192_bb0610","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.omtn.2023.05.007","article-title":"Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells","volume":"32","author":"Porquet","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.nbd.2025.107192_bb0615","doi-asserted-by":"crossref","DOI":"10.1172\/JCI185426","article-title":"The Splice Index as a prognostic biomarker of strength and function in myotonic dystrophy type 1","volume":"135","author":"Provenzano","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2025.107192_bb0620","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/PDM.0b013e3181efe290","article-title":"Effect of unexpected sequence interruptions to conventional PCR and repeat primed PCR in myotonic dystrophy type 1 testing","volume":"20","author":"Radvansky","year":"2011","journal-title":"Diagn. Mol. Pathol."},{"key":"10.1016\/j.nbd.2025.107192_bb0625","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.nmd.2013.02.013","article-title":"Uninterrupted CCTG tracts in the myotonic dystrophy type 2 associated locus","volume":"23","author":"Radvanszky","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.nbd.2025.107192_bb0630","doi-asserted-by":"crossref","first-page":"8272","DOI":"10.1038\/s41467-023-43872-1","article-title":"The ALS\/FTD-related C9orf72 hexanucleotide repeat expansion forms RNA condensates through multimolecular G-quadruplexes","volume":"14","author":"Raguseo","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.107192_bb0635","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41582-025-01139-x","article-title":"Myotonic dystrophy type 1: clinical diversity, molecular insights and therapeutic perspectives","volume":"21","author":"Rahm","year":"2025","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0640","article-title":"Single-AAV CRISPR editing of skeletal muscle in non-human primates with NanoCas, an ultracompact nuclease","author":"Rauch","year":"2025","journal-title":"bioRxiv [preprint]"},{"key":"10.1016\/j.nbd.2025.107192_bb0645","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9orf72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.107192_bb0650","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41467-024-45535-1","article-title":"Chronic endoplasmic reticulum stress in myotonic dystrophy type 2 promotes autoimmunity via mitochondrial DNA release","volume":"15","author":"R\u00f6sing","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.107192_bb0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-023-02652-3","article-title":"G2C4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS\/FTD induced pluripotent stem cell derived neurons","volume":"147","author":"Rothstein","year":"2023","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.107192_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.xgen.2024.100679","article-title":"Mechanism-free repurposing of drugs for C9orf72-related ALS\/FTD using large-scale genomic data","volume":"4","author":"Saez-Atienzar","year":"2024","journal-title":"Cell Genomics"},{"key":"10.1016\/j.nbd.2025.107192_bb0665","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41598-023-50667-3","article-title":"Validated assays for the quantification of C9orf72 human pathology","volume":"14","author":"Salomonsson","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.107192_bb0670","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ijcard.2012.11.076","article-title":"The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes","volume":"168","author":"Sansone","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.nbd.2025.107192_bb0675","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s40120-023-00548-8","article-title":"Roadmap for C9ORF72 in frontotemporal dementia and amyotrophic lateral sclerosis: report on the C9ORF72 FTD\/ALS Summit","volume":"12","author":"Sattler","year":"2023","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.nbd.2025.107192_bb0680","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ng704","article-title":"Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy","volume":"29","author":"Savkur","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2025.107192_bb0685","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1086\/421528","article-title":"Insulin receptor splicing alteration in myotonic dystrophy type 2","volume":"74","author":"Savkur","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2025.107192_bb0690","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1038\/s41467-019-12740-2","article-title":"Phase separation-deficient TDP43 remains functional in splicing","volume":"10","author":"Schmidt","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.107192_bb0695","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1212\/01.WNL.0000147335.10783.E4","article-title":"Sudden cardiac death in myotonic dystrophy type 2","volume":"63","author":"Schoser","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.107192_bb0700","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg7162","article-title":"Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS\/FTD","volume":"16","author":"Seddighi","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2025.107192_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2024.101145","article-title":"Myotonic dystrophy type 1 testing, 2024 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"26","author":"Seifert","year":"2024","journal-title":"Genet. Med."},{"key":"10.1016\/j.nbd.2025.107192_bb0710","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41419-020-03112-6","article-title":"miR-322\/-503 rescues myoblast defects in myotonic dystrophy type 1 cell model by targeting CUG repeats","volume":"11","author":"Shen","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2025.107192_bb0715","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/brain\/awr355","article-title":"Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9orf72 mutations","volume":"135","author":"Snowden","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107192_bb0720","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83189","article-title":"Translation of dipeptide repeat proteins in C9ORF72 ALS\/FTD through unique and redundant AUG initiation codons","volume":"12","author":"Sonobe","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.nbd.2025.107192_bb0725","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.3390\/ijms20133365","article-title":"Short tandem repeat expansions and RNA-mediated pathogenesis in myotonic dystrophy","volume":"20","author":"Sznajder","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.107192_bb0730","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41593-025-01943-0","article-title":"Autism-related traits in myotonic dystrophy type 1 model mice are due to MBNL sequestration and RNA mis-splicing of autism-risk genes","volume":"28","author":"Sznajder","year":"2025","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2025.107192_bb0735","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2025.107192_bb0740","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13024-020-00383-7","article-title":"Divergence, convergence, and therapeutic implications: a cell biology perspective of C9orf72-ALS\/FTD","volume":"15","author":"Tang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2025.107192_bb0745","series-title":"Results from Phase 2 study of TPN-101 for C9orf72-related ALS\/FTD","author":"Transposon Therapeutics","year":"2024"},{"key":"10.1016\/j.nbd.2025.107192_bb0750","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/dmcn.16079","article-title":"Parental diagnostic delay and developmental outcomes in congenital and childhood-onset myotonic dystrophy type 1","volume":"67","author":"Trucco","year":"2025","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0755","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S1474-4422(13)70210-2","article-title":"Association between repeat sizes and clinical and pathological characteristics in carriers of C9orf72 repeat expansions (Xpansize-72): a cross-sectional cohort study","volume":"12","author":"van Blitterswijk","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0760","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1474-4422(24)00216-3","article-title":"Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis","volume":"23","author":"van den Berg","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.107192_bb0770","doi-asserted-by":"crossref","first-page":"fcae288","DOI":"10.1093\/braincomms\/fcae288","article-title":"Comparative analysis of neurofilaments and biomarkers of muscular damage in amyotrophic lateral sclerosis","volume":"6","author":"Vidovic","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.nbd.2025.107192_bb0775","first-page":"252","article-title":"Metabolic impairments in patients with myotonic dystrophy type 2","volume":"37","author":"Vujnic","year":"2018","journal-title":"Acta Myol."},{"key":"10.1016\/j.nbd.2025.107192_bb0780","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006316","article-title":"Dose-dependent regulation of alternative splicing by MBNL proteins reveals biomarkers for myotonic dystrophy","volume":"12","author":"Wagner","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2025.107192_bb0785","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/jama.2012.346","article-title":"Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease","volume":"307","author":"Wahbi","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.nbd.2025.107192_bb0790","first-page":"751","article-title":"Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1","volume":"38","author":"Wahbi","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.nbd.2025.107192_bb0795","article-title":"pTDP-43 levels correlate with cell type-specific molecular alterations in the prefrontal cortex of C9orf72 ALS\/FTD patients","volume":"122","author":"Wang","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.107192_bb0800","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40478-025-01977-2","article-title":"C9orf72 poly-PR disrupts expression of ALS\/FTD-implicated STMN2 through SRSF7","volume":"13","author":"Wang","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2025.107192_bb0805","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1261\/rna.610607","article-title":"MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T","volume":"13","author":"Warf","year":"2007","journal-title":"RNA"},{"key":"10.1016\/j.nbd.2025.107192_bb0810","series-title":"Wave Life Sciences announces topline results from phase 1b\/2a FOCUS-C9 clinical trial","author":"Wave Life Sciences","year":"2023"},{"key":"10.1016\/j.nbd.2025.107192_bb0815","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1016\/j.neuron.2024.07.025","article-title":"Disruption of nuclear speckle integrity dysregulates RNA splicing in C9ORF72-FTD\/ALS","volume":"112","author":"Wu","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.107192_bb0820","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature14973","article-title":"The C9orf72 repeat expansion disrupts nucleocytoplasmic transport","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.107192_bb0825","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.neuron.2017.08.039","article-title":"RAN translation regulated by muscleblind proteins in myotonic dystrophy type 2","volume":"95","author":"Zu","year":"2017","journal-title":"Neuron"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125004097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125004097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T11:25:43Z","timestamp":1766143543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125004097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":159,"alternative-id":["S0969996125004097"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107192","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From molecular convergence to clinical divergence: Comparative pathogenic mechanisms and therapeutic trajectories in C9orf72-ALS\/FTD and myotonic dystrophy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107192"}}